GH Research (GHRS) Shares Outstanding (Weighted Average) (2020 - 2025)

GH Research (GHRS) recorded quarterly Shares Outstanding (Weighted Average) of $454.2 million in Q4 2025, up 81102757.14% quarter-over-quarter from $560.0 in Q3 2025, and up 49.19% on a YoY basis from $304.4 million in Q4 2024.

GH Research (GHRS) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends

GH Research's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $454.2 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Weighted Average) rose 49.19% year-over-year to $454.2 million; the TTM figure through Dec 2025 stood at $454.2 million (up 49.19% YoY), while the FY2025 annual figure was $454.2 million, up 772.94% from the prior year.
  • Shares Outstanding (Weighted Average) was $454.2 million for Q4 2025 at GH Research, up from $560.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2022 to a low of $100.0 in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $516.2 million across 5 years, with a median of $304.4 million in 2021.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) soared 361388788.89% in 2024, then slumped 100.0% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $304.4 million in 2021, then changed by 0.0% to $304.4 million in 2022, then sank by 82.91% to $52.0 million in 2023, then surged by 485.18% to $304.4 million in 2024, then surged by 49.19% to $454.2 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $454.2 million (Q4 2025), $560.0 (Q3 2025), and $330.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 185,491.37 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 400.00 Bn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4,489.46 Bn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 118.76 Bn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 417.01 Bn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 254.10 Mn
9 Abivax 94.26 Bn 94.26 Bn - 928.40 Mn
10 GH Research 9.73 Bn 9.63 Bn - 454.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 454.18 Mn
Sep 30, 2025 560.00
Jun 30, 2025 330.00
Mar 31, 2025 190.00
Dec 31, 2024 304.43 Mn
Sep 30, 2024 1.30 Bn
Jun 30, 2024 1.30 Bn
Mar 31, 2024 1.30 Bn
Dec 31, 2023 52.02 Mn
Sep 30, 2023 470.00
Jun 30, 2023 360.00
Mar 31, 2023 1.30 Bn
Dec 31, 2022 304.41 Mn
Sep 30, 2022 1.30 Bn
Jun 30, 2022 100.00
Mar 31, 2022 1.30 Bn
Dec 31, 2021 304.41 Mn
Sep 30, 2021 291.45 Mn
Jun 30, 2021 291.51 Mn
Dec 31, 2020 5.43 Mn